The purity of T cells derived from AML patients was much lower compared to enriched T cells from healthy donors, which could be traced back to the presence of CD33+ and CD123+ cells indicative for AML cells (Figure S4B). The gene discussed is CD33; the disease is acute myeloid leukemia.